...
首页> 外文期刊>International journal of oral and maxillofacial surgery >A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone.
【24h】

A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone.

机译:在上颌骨骨化性纤维瘤的治疗中发现一例甲状旁腺功能亢进症。

获取原文
获取原文并翻译 | 示例
           

摘要

Hyperparathyroidism-jaw tumour (HPT-JT) syndrome is characterized by parathyroid tumours as well as by ossifying fibromas of the mandible and maxilla, renal cysts, or Wilms' tumours. Recently, the gene responsible for HPT-JT syndrome has been identified as the HRPT2 tumour suppressor gene. In an 18-year-old male, a tumour in the maxilla was first diagnosed as an ossifying fibroma. During biochemical screening before surgery, the patient received a diagnosis of primary hyperparathyroidism. Neck computed tomography scanning showed a parathyroid tumour. Surgical excisions to remove the jaw tumour and parathyroid adenoma were performed. The postoperative course has been uneventful and a follow up at 2 years revealed no evidence of recurrence. The HRPT2 germline mutation of 39delC was detected in the proband, but not in his unaffected parents. These results suggested that the germline mutation occurred de novo.
机译:甲状旁腺功能亢进症(HPT-JT)综合征的特征在于甲状旁腺肿瘤,以及下颌骨和上颌骨的纤维瘤,肾囊肿或威尔姆氏瘤的骨化。近来,已将负责HPT-JT综合征的基因鉴定为HRPT2肿瘤抑制基因。在一名18岁男性中,上颌骨肿瘤首先被诊断为骨化性纤维瘤。在手术前的生化检查中,患者被诊断为原发性甲状旁腺功能亢进。颈部计算机断层扫描显示甲状旁腺肿瘤。进行手术切除以去除颌骨肿瘤和甲状旁腺腺瘤。术后过程平稳,在2年的随访中没有发现复发的迹象。在先证者中检测到39delC的HRPT2种系突变,但在未受影响的父母中未检测到。这些结果表明种系突变从头开始发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号